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studies suggested that in more than two-thirds of patients, acute myocardial infarction (AMI) evolves
from mild to moderate (<70%) stenosis. This observation has been a paradigm for many years, sug-
gesting that unexpected thrombus formation was the main preventive target for acute coronary events.
Yet, published data challenge this paradigm. Indeed, both angiographic studies as well as studies per-
formed using intravascular imaging show that stenosis severity underlying an AMI is variable and often
severe. The information provided by intracoronary imaging also suggests qualitative and quantitative
heterogeneity of infarct-related plaques. The knowledge of this heterogeneity is likely to have major
clinical implications.Yes!
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Although important advancements have been
pursued in the knowledge of mechanisms of
coronary instability, severity of the underlying
coronary stenosis leading to AMI is still debated.
In particular, at the end of the 1980s a paradigm
emerged from data of retrospective angiographic
studies suggesting that inmore than two-thirds of
patients AMI evolves from mild to moderate
(<70%) stenosis (1–3). However, data provided
by pathologists have been contradictory. In par-
ticular, in a post-mortem study in 162 patients
who died of AMI, mean percent luminal area
reduction at sites of coronary thrombus was 91%
(4). In another study by Davies and Thomas (5),
74 of 100 subjects who died within 6 h of an
ischemic cardiac arrest had coronary thrombus;
percent luminal area reduction at sites of coronarythrombus was $75% in 65% of cases. Finally,
Narula et al. (6) found that mean percent vascular
area involvement at sites of coronary thrombus
was almost always more than 50%. Furthermore,
the paradigm arising from angiographic studies is
challenged by the wide range of time intervals
between the ﬁrst angiogram and AMI, and that a
long time interval does not take into account the
possibility of plaque progression between the two
coronary angiograms as suggested by the frequent
observation of angina onset some months before
AMI (7). It is important to consider prospective
angiographic studies: 1) focused on the pro-
gression to occlusive disease of coronary athero-
sclerosis; 2) performed in patients treated by
thrombolysis or primary percutaneous coronary
intervention (PCI) (8–18); and 3) pertaining to
culprit lesion evaluation by intravascular imaging
in the setting of AMI.
Early angiographic and post-ﬁbrinolysis studies.
Little et al. (1) in a study enrolling 42 patients
demonstrated that in 66% of patients the artery
that subsequently occluded had <50% stenosis
on the initial angiogram. Of note, the ﬁrst
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1109angiogram was performed 706  685
days before AMI. Similar observations
were reported by Ambrose et al. (2).
Indeed, Dacanay et al. (3) showed that
among patients with Q-wave and a ﬁrst
angiogram <18 months before AMI,
82% had stenosis severity >50% as
compared with only 33% when the ﬁrst
angiogram was>18 months from AMI,
(Fig. 1). Similar ﬁndings have been
reported by Ojio et al. (19). More
recently, Zaman et al. (20), in a
population of 41 patients with ST-
segment elevation myocardial infarc-
tion (STEMI) and a previous coronary
angiography showed that lesions leading
to STEMI #3 months after evaluation
were more severe than those leading to
STEMI in>3 months before MI (59
31% vs. 36  21%, p ¼ 0.02). Interest-
ingly, Ojio et al. (19) and Zaman et al.
(20) observed angiographic features of
complex lesions in a variable proportion
of patients (60% and 20%, respectively)
at the angiogram preceding AMI, and
may suggest that changes in plaque
activity might have contributed to pro-
gression of lesion severity, in keepingwith
pathological studies showing that both
multiple plaque ruptures and intraplaque
hemorrhagemay cause lesion progression
even in the absence of an acute coronary
syndrome (ACS) (21).
Apart from the large time interval
between the 2 coronary angiograms, early
studies were limited by a retrospective
design thatmay have introduced selection
biases, while prospective studies indeed
provided different information. In0
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Figure 1. Severity of Coronary Stenosis According t
and Subsequent Acute MI
Shorter time intervals are associated with greater stenparticular, the largest available pro-
spective evidence comes from the CASS
(Coronary Artery Surgery Study) study
(8). In a cohort of 314 patients treated
either medically or by coronary artery
bypass graft surgery (CABG) that
underwent a repeat coronary angiography
within a 42- to 66-month period, the
authors were able to show that the most
important predictor of new segment
occlusion both in patients treated med-
ically and by CABG was the initial se-
verity of lesion. In particular, in patients
treated medically only 2.3% of stenosis
<50% showed occlusion as compared
with 13.5% of stenosis 50% to 95% and
to 23.6% of stenosis 81% to 95%.
Other information that challenged
initial studies focused on the angio-
graphic severity of underlying stenosis
leading to AMI were provided by the
use of early thrombolysis in STEMI.
Mathey et al. (9) showed that in
patients presenting with STEMI the
existence of high-grade ﬁxed coronary
stenosis prompted CABG. This should
be taken into account as the presence of
residual thrombus may overestimate
lesion severity by angiography. How-
ever, independently of time of the
repeat angiography, from 2 weeks in the
study by Van Lierde et al. (11) to 5
weeks in that by Brown et al. (12),
mean percent diameter stenosis in
recanalized culprit vessels was around
60% by quantitative coronary analysis
(QCA), suggesting that severe lesions
may underlie coronary thrombosis at
least in a subset of patients.r
jio S et al, 2000
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osis severity. MI ¼ myocardial infarction.Angiographic severity of culprit stenosis
at the time of primary PCI. Percuta-
neous coronary reperfusion in the setting
of AMI allows direct angiographic esti-
mation of the underlying stenosis
severity. Most randomized trials inves-
tigating the use of coronary stents have
reported angiographic severity of culprit
lesions as >80% diameter stenosis
(Fig. 2) (13–18). However, the presence
of thrombotic material within the culprit
lesion might have resulted in an over-
estimation of the degree of stenosis
severity in these studies. In order to
overcome this limitation Frøbert et al.
(22) performed an observational study
restricting QCA to culprit lesions of
patients with STEMI inwhom a realistic
estimate of stenosis severity could be
made, wherein of 156 patients, 149
(96%) presented with an underlying
diameter stenosis severity>50% and 103
patients (66%) presented with a diameter
stenosis severity >75%. Similarly, Man-
oharan et al. (23) observed signiﬁcant
stenosis severity in 135 patients with
non–ST-segment elevation ACS (72 
11%) and in 102 patients with STEMI
(66  12%) after successful thrombus
aspiration; only a minority (z10%) of
patients with STEMIhad a culprit lesion
with a diameter stenosis <50% (23,24).
These ﬁndings suggest that the majority
of acute coronary events occur at the site
of severe rather than mild coronary
stenoses.
Intracoronary imaging: severity and
characteristics of the culprit lesion in
patients with STEMI. Intracoronary
imaging with intravascular ultrasound
(IVUS) and optical coherence tomog-
raphy (OCT) has provided important
insights about culprit lesions severity
and morphology in patients with
STEMI.
Kotani et al. (25), by using grayscale
IVUS in 38 consecutive AMI patients,
showed that culprit lesions as compared
with nonculprit lesions and non–
infarct-related artery lesions had smaller
lumens (2  0.9 vs. 4.1  3.1 vs. 3.4 
2.5 mm2, p ¼ 0.009). Fujii et al. (26)
found that a smaller minimum cross-
sectional lumen area and the presence
Figure 2. Mean Pre-Procedural Percent Diameter Stenosis of STEMI Culprit Lesions According to QCA
Data refer to major studies with available quantitative coronary angiography (QCA) analysis in the setting of
primary percutaneous coronary intervention. COMFORTABLE ¼ Comparison of Biolimus Eluted From an
Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction; HORIZONS-AMI ¼
Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction; MISSION ¼ A
Prospective Randomised Controlled Trial to Evaluate the Efﬁcacy of Drug-Eluting Stents versus Bare-Metal
Stents for the Treatment of Acute Myocardial Infarction; PASEO ¼ PaclitAxel or Sirolimus-Eluting Stent Versus
Bare Metal Stent in Primary Angioplasty; PASSION ¼ Paclitaxel Eluting Stent Versus Conventional Stent in ST-
segment Elevation Myocardial Infarction; STEMI ¼ ST-segment elevation myocardial infarction; TYPHOON ¼
Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty.
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1110of thrombus were independent pre-
dictors of ACS. IVUS has helped in
the clariﬁcation of the frequent dis-
sociation between post-mortem data
and angiographic severity of coronary
stenosis due to expansive (positive)
vessel remodeling.
Finally, data from the PROSPECT
(Providing Regional Observations to
Study Predictors of Events in the
Coronary Tree) study have suggested
that a small luminal area (i.e., minimal
luminal area #4 mm2) is independently
associated with the 3-year risk of acute
coronary events (27). In a substudy of
the PROSPECT study, increasing
baseline angiographic diameter stenosis
was associated with an increased risk of
major cardiovascular events (28), and
that one-third of non–culprit lesion-
related events showed a diameter ste-
nosis >50% at baseline (29). Regarding
the evaluation of lesion severity by
OCT, it is worth mentioning a recent
OCT study that showed in patients
with ACS a mean area stenosis of about
80% (30).
Conclusions. The extent of stenosis
underlying an AMI is heterogeneous,
ranging from mild to severe. This het-
erogeneity suggests that either stenosis
severity is a pure epiphenomenon not
related to thrombus formation or thatdifferent pathogenetic mechanisms of
coronary thrombosis may operate
according to stenosis severity, a concept
that needs to be further explored. Thus,
some patients may have a moderate
stenosis associated with strong throm-
bogenic stimuli, while others may have
a severe stenosis causing an acute cor-
onary syndrome, possibly in the absence
of a strong thrombogenic stimulus.
Patients with severe stenosis indeed
may develop an acute coronary syndrome
due to shear stress–related thrombus
formation (31). Furthermore, especially
when a history of progressive recent
angina is present, rapid plaque pro-
gression may lead to acute coronary syn-
drome due to intraplaque hemorrhage
that is strictly linked to plaque inﬂam-
mation (21). A recent OCT study
showed that plaque progression was
associated with the presence of TCFA
and microchannels (32).
In contrast, patients with a moderate
to mild stenosis presenting an ACS may
be characterized by a potent thrombo-
genic stimulus. Some of the cases might
be related to coronary erosion which is
more often observed in women and
smokers and characterized by less severe
stenosis as compared with ﬁssured pla-
ques in post-mortem studies (33). Other
patients may, however, have sustainedvasoconstriction leading to thrombosis
because of blood stagnation (34).
No!
John A. Ambrose, MDx
Ryan Berg, MDx
Acute thrombosis on a disrupted or
eroded atherosclerotic plaque is res-
ponsible for acute myocardial infarction
(AMI) in nearly all cases of type 1
infarction by the universal deﬁnition
(35). In the 1980s and early 1990s,
several small, retrospective angiographic
studies in which patients had prior
angiograms available revealed a sur-
prising ﬁnding. In most patients, the
culprit site responsible for subsequent
AMI was usually <50% diameter
stenotic on the ﬁrst study. In many
cases, the culprit site appeared normal
(1,2,36–38). Additional data from
other angiographic studies, intra-
vascular ultrasound (IVUS) analyses,
and pathologic studies at autopsy sup-
ported the concept that angiography
underestimated plaque size, that
angiographic results might appear nor-
mal even with large plaque burden
related to positive remodeling (39), and
that plaque was often nonobstructive
before the acute event. Over time, this
concept became accepted by cardiolo-
gists and was even incorporated into the
characteristics of vulnerable plaque (40).
Nevertheless, if the preceding plaque
was not angiographically severe, an-
giography at the onset of AMI usually
depicted total occlusion. How could
this occur? A contrary opinion to the
idea of a mild angiographic lesion
suggested that the lesion preceding
myocardial infarction (MI) is not mild
but usually severe, on the basis of sev-
eral other data presented in the fol-
lowing discussion. In this report, we
revisit the concept of the “mild diame-
ter stenosis lesion” before MI and sug-
gest how the contrary opinion does not
contradict the concept of the mild
lesion.
To examine the relationship between
angiography and AMI pathogenesis, 3
Figure 3. Theoretic Cross Sections of a Coronary Artery at Different Stages in the Evolution to STEMI
The left panel demonstrates a thin-capped ﬁbroatheroma (TCFA) with positive remodeling and only mild
luminal narrowing. The second panel from the left depicts an artery with some progression and an
asymptomatic plaque rupture with intraluminal thrombus formation. The lumen begins to narrow. This
asymptomatic progression to ST-segment elevation myocardial infarction (STEMI) is accelerated in the days
to weeks before the event. The third panel depicts the thrombosed plaque of an acute STEMI that has
completely obliterated the lumen with acute thrombus over layered thrombus. After thrombolytic therapy
or mechanical thrombectomy, the last panel depicts an open but still signiﬁcantly narrowed arterial cross-
section with both plaque and residual thrombus occluding the lumen. Illustration by Dr. Fridolin Sy.
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1111time intervals should be assessed: 1)
remote from AMI, when the respon-
sible plaque is quiescent; 2) just before
AMI; and 3) immediately after suc-
cessful thrombolytic therapy or throm-
bectomy (Fig. 3). This discussion is
limited for the most part to ST-seg-
ment elevation myocardial infarction
(STEMI), previously deﬁned as trans-
mural or Q-wave AMI.
Angiographic narrowing remote from
AMI. Other recent studies have sup-
ported the concept of the mild lesion,
although not all cases were in patients
with STEMI. These are presented to
indicate a pattern seen in most studies
related to acute coronary syndrome
(ACS) and AMI pathogenesis.
In 2005, Glaser et al. (41) reported
on 216 patients who required additional
angiography for clinical progression at 1
year of a nontarget lesion. Fifty-nine
percent presented with unstable angina
and 9% with nonfatal MI. A majority of
lesions (60.5% [95 of 157]) were <50%
initially, and only 13% were >70%.
These percents were similar to those
seen in the studies of the 1980s.
Furthermore, in the PROSPECTstudy, nonculprit events represented
nearly 50% of all repeat events at 3
years. IVUS in a subgroup with visual
angiographic narrowing >30% indi-
cated that the responsible lesion at
baseline was often a thin-capped
ﬁbroatheroma (TCFA) with large pla-
que volume and small cross-sectional
area. Nevertheless, the mean diameter
stenosis was 32.3  20.6%, and 59%
were <50%. Thirty percent were <30%
stenotic, and it is uncertain how many
were interrogated with IVUS, as only
52% of nonculprit lesions with events
were studied (27).
Pathologic studies after fatal AMI or
sudden coronary death indicate that
plaque rupture of a TCFA is seen in
two-thirds to three-quarters of culprit
thrombosed plaques (21). Asympto-
matic TCFAs in general are not severely
narrowed. Eighty percent have <75%
area stenosis, which corresponds to
<50% diameter stenosis (42). Thus,
before STEMI or in ACS, the plaque
responsible for the subsequent event
may be large but is often nonobstructive.
Not all studies indicate that mild le-
sions precede ACS and even transmuralMI. Five-year angiographic follow-up
from participants in CASS (Coronary
Artery Surgical Study) indicated, on the
basis of qualitative analysis of the
angiograms, that severe lesions (>80%
diameter narrowing on the ﬁrst angio-
gram) were most likely to totally occlude
on follow-up (8). However, no clinical
data were available to assess their
symptoms. Furthermore, there were
many more lesions that were milder or
<80% narrowed that occluded on the
repeat study (71% [52 of 73]), while only
29% were >80% initially. Subsequently,
Ellis et al. (43) found that the highest
risk for subsequent anterior MI (either
transmural or nontransmural) from
CASS was a severe stenosis (90% to
98%) in the left anterior descending
coronary artery. However, angiographic
follow-up after the infarction was not
available to conﬁrm the severe stenosis as
the culprit lesion (43). Similarly, Buch-
wald et al. (44) concluded that severe
lesions preceded most transmural or Q-
wave infarcts. Again, follow-up angiog-
raphy was not available (44).
The last study of import comes from
Mancini et al. (45), who analyzed 61 of
119 patients (56%) with optimal med-
ical therapy who subsequently had
AMIs and subsequent angiographic
studies, as well as other patients with
ACS without AMI or just more angina.
Lesions with <50% diameter stenosis
at baseline were responsible for only
one-third of events. Patients with
AMIs were not analyzed separately, and
particularly in those with STEMIs,
baseline angiographic data were not
reported. Thus, of the 3 studies above,
2 (Ellis et al. [43] and Buchwald et al.
[44]) did not have follow-up angio-
grams to document infarct site location,
and 2 (Ellis et al. [43] and Mancini et
al. [45]) included both STEMI and
non-STEMI in their analyses. Because
of these discrepancies, these data do not
undermine the mild lesion argument.
Angiograhic narrowing in the days
to weeks before AMI. Two studies
assessed angiographic narrowing imme-
diately before STEMI. Ojio et al. (19)
retrospectively assessed 40 patients with
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similar to the analyses reportedpreviously.
However, when they analyzed the
angiographic narrowing in 20 patients,
obtained 3  3 days before Q-wave (n¼
12) or non–Q-wave (n ¼ 8) AMI, the
narrowing averaged 71  12% at the
culprit site, while it was 30 18% in the
20 control subjects withﬁrst angiographic
studies 6 to 18 months before their sub-
sequent AMI events. Likewise, Zaman et
al. (20) found that lesions leading to
STEMIweremoreoftennarrowedon the
ﬁrst angiogram if the clinical event was
#3 months after the initial angiogram (n
¼ 7) compared with>3months (n¼ 34)
(59  31% vs. 36  21% diameter
stenosis, respectively, p ¼ 0.02).
However, why were these patients
studied right before AMI? The likely
answer is that they were either sympto-
matic with new-onset unstable angina
and/or a lesion had asymptomatically
destabilized but had not totally occluded
before AMI. In support of that hypoth-
esis, 70% of patients with an angiogram
3 days before AMI had angiographic
evidence of acute, complex culprit
lesions (19), as described originally by
Ambrose et al. (46), while these lesions
were infrequent in controls (10%). These
complex lesions indicate plaque dis-
ruption and/or intracoronary thrombus.
Thus, this group with more than mild
lesions just happened to be studied
immediately before the onset of either
Q-wave or non-Q-wave MI. Growth of
the plaque and narrowing of the lumen
must occur at some point prior to the
onset of AMI as the lesion progresses to
total or near total occlusion at the time of
AMI. Pathologically, autopsy studies
indicate that the thrombosed lesion
responsible for fatal MI or sudden cor-
onary death contains both acute and
healed thrombus (47,48). Multiple epi-
sodes of asymptomatic thrombus for-
mation usually precede the fatal event.
Pathologic analysis of thrombectomy
specimens at the time of primary percu-
taneous coronary intervention in
patients with STEMIs have also indi-
cated that organized thrombus can be
extracted in more than 50% of patients(49). This also suggests some chronicity
to the process. Finally, if one considers
unstable angina to be the forerunner to
AMI, particularly if untreated, plaque
disruption and/or thrombus (a complex
plaque) with a severe stenosis will be seen
in >70% of cases in the culprit on
angiography, while total occlusion is
unusual (46,50). These processes help
explain the ﬁndings of Ojio et al. (19)
and Zaman et al. (20).
Angiographic narrowing immediately
after thrombolytics or thrombectomy.
After the successful opening of a totally
occluded vessel with thrombolytic ther-
apy or after mechanical thrombectomy,
the culprit lesion is generally severely
narrowed. This has been used to support
the concept that a severe lesion usually
precedes MI. Thus, in 151 patients with
STEMI with spontaneous reﬂow or
with immediate reﬂow after uncom-
plicated wiring of the lesion but be-
fore primary percutaneous coronary
intervention, the underlying diameter
stenosis was >50% in 96%, and in 66%,
it was >70% (22). Similar ﬁndings were
also reported by Manoharan et al. (23).
The underlying culprit lesion after
mechanical thrombectomy was severe in
nearly all and was <50% in only 11%.
However, does the residual stenosis
represent only plaque? Brown et al. (12)
showed that residual thrombus is pres-
ent following thrombolytic reopening
of a vessel and that the underlying
plaque was only moderate. Follow-up
angiography in 2 different studies per-
formed hours to weeks after thrombo-
lytic therapy to allow endogenous
thrombolysis showed that the residual
diameter narrowing was moderate (50%
to 57%) on follow-up (10,11). Patho-
logic studies after fatal MI also support
the concept that the underlying culprit
plaque (excluding acute thrombus) may
not be severely narrowed. However,
unless postmortem preparations pres-
sure ﬁx arteries, the degree of stenosis
will be overestimated.
Such was the case in the study of
Qiao and Fishbein (4), who found
thrombosis on plaques that had a mean
stenosis of 91%. With pressure ﬁxation,Davies and Thomas (5) showed that
the average area stenosis was 79%,
corresponding to a diameter stenosis of
52%. Furthermore, heightened vaso-
motion in epicardial arteries and in the
microvasculature is common in STEMI
and could increase residual diameter
narrowing acutely (51).
Optical coherence tomography
(OCT) and IVUS studies after throm-
bectomy are ﬂawed and have added
little concerning the degree of under-
lying area stenosis. IVUS cannot reli-
ably distinguish between plaque and
thrombus (52). Therefore, unless com-
plete thrombectomy is done, the mea-
sured IVUS stenosis area is prone to
signiﬁcant overestimation. Hong et al.
(53) assessed IVUS images in 125
patients with STEMIs. Thrombus at
the culprit lesion was not completely
removed even after thrombectomy.
Although OCT has better resolution
than IVUS (54), the yellow-orange
color scale typically used in current
Fourier transformation OCT may not
easily distinguish it from surrounding
plaque (55). Furthermore, lipid-rich
plaque or thrombus causes OCT signal
attenuation, which confounds accurate
area measurements behind plaque and
thrombus. Other studies using OCT in
AMI (2,24) are also ﬂawed in quanti-
fying luminal narrowing by the lack of
complete thrombus aspiration.
In conclusion, these data in total
strongly support that in a majority but
not in all cases, mild angiographic
lesions usually precede STEMI in the
months before AMI. These lesions are
quiescent and usually are TCFAs on
pathologic or intravascular analysis, in
which positive remodeling has main-
tained luminal area despite being large
plaques. However, in the days to weeks
before STEMI, some are transformed
through rapid progression from intra-
luminal thrombus formation or intra-
plaque hemorrhage into truly vulnerable
plaques that subsequently progress
to symptomatic, total coronary occlu-
sion. Most patients who subsequently
develop STEMIs are not fortunate to
undergo angiography in time to detect
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1113this rapid progression and eventual
occlusion, as they are either asympto-
matic beforehand or misinterpret their
symptomatology.
Finally, this concept of whether or
not a lesion is mild or severe should not
be considered frivolous. STEMI still
accounts for hundreds of thousands of
events each year. The demonstration of
coronary atherosclerosis either through
invasive angiography or otherwise is a
premonitory sign that can occasionally
progress to an acute and sometimes
fatal event. Obviously, invasive angi-
ography is insensitive to plaque size
and atherosclerotic plaque burden.
Nevertheless, the demonstration of
atherosclerosis without severe diameter
narrowing must be treated as aggres-
sively medically as when severe disease
is demonstrated. Otherwise, we per-
form a great disservice to our patients
by reinventing the past!However, we also do not want to
assume that only mild stenoses have
vulnerable potential and to not worry
about ﬁxing severe lesions. Although a
majority of lesions leading to STEMI
are not severely narrowed before the
event, there are still some, as noted even
in the earlier angiographic studies, that
do have moderate or severe stenosis
beforehand. Furthermore, as mentioned
earlier, some severe stenoses are in the
active process of transformation from
prior mildly stenotic vulnerable plaques
and require consideration for invasive
management.
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